EEG-Neurofeedback and Psychodynamic Psychotherapy in a Case of Adolescent Anhedonia With Substance Misuse: Mood/theta Relations.
EEG-Neurofeedback and Psychodynamic Psychotherapy in a case of Adolescent Anhedonia with Substance Misuse: Mood/theta relations.
Int J Psychophysiol. 2013 Mar 24;
Unterrainer HF, Chen MJ, Gruzelier JH
Exploration of “Food Addiction” in Overweight and Obese Treatment-Seeking Adults.
Appetite. 2013 Mar 24;
Eichen DM, Lent MR, Goldbacher E, Foster GD
There is growing interest in conceptualizing obesity as a “food addiction.” The current study investigated the prevalence and correlates of “food addiction” (FA), as defined by the Yale Food Addiction Scale (YFAS) in 178 (133 F, 45M) persons seeking weight loss treatment. Participants had a mean age of 51.2±11.7 years and a body mass index of 36.1±4.8 kg/m(2). Fifteen percent of individuals met the YFAS proposed diagnostic criteria for FA. Those who met criteria for FA reported significantly greater depressive symptomatology. There were no differences in BMI, age, race, or gender between participants with and without FA. Among those not meeting criteria, 35% reported 3 or more symptoms in the absence of self-reported clinical distress or impairment. YFAS symptom count was also significantly correlated with depressive symptoms. These findings suggest that 15% of adults presenting for weight loss treatment meet YFAS criteria for FA. The clinical significance of this classification is unknown and needs to be validated in prospective studies. HubMed – addiction
The delivery of smoking cessation interventions to primary care patients with mental health problems.
Addiction. 2013 Mar 27;
Szatkowski L, McNeill A
AIMS: To quantify the extent to which smokers with indicators of poor mental health receive smoking cessation support in primary care consultations compared with those without. DESIGN: Cross-sectional study within a database of electronic primary care medical records. SETTING: A total of 495 general practices in the United Kingdom contributing data to The Health Improvement Network (THIN) database. PARTICIPANTS: A total of 2?493?085 patients aged 16+ registered with a THIN practice for the year from 1 July 2009 to 30 June 2010. MEASUREMENTS: The proportion of patients with a diagnostic Read code or British National Formulary (BNF) drug code indicating a mental health diagnosis or psychoactive medication prescription, respectively, who smoke and who have cessation advice or a smoking cessation medication prescription recorded during consultations within the 1-year study period. FINDINGS: Of 32?154 smokers, 50.6% [95% confidence interval (CI): 50.0-51.2] with a mental health diagnosis and 49.3% (95% CI: 49.0-49.7) of 96?285 smokers prescribed a psychoactive medication had a record of cessation advice, higher than the prevalence of advice recording in smokers without these indicators (33.4%, 95% CI: 33.3-33.6). Similarly, smoking cessation medication prescribing was higher: 11.2% (95% CI: 10.8-11.6) of smokers with a mental health diagnosis and 11.0% (95% CI: 10.8-11.2) of smokers prescribed psychoactive medication received a prescription, compared with 6.73% of smokers without these indicators (95% CI: 6.65-6.81). Smoking cessation support was offered in a lower proportion of consultations for smokers with indicators of poor mental health than for those without. Advice was recorded in 7.9% of consultations with smokers with a mental health diagnosis, 8.2% of consultations with smokers prescribed psychoactive medication and 12.3% of consultations with smokers without these indicators; comparable figures for prescribing of cessation medication were 2.9%, 3.2% and 4.4%, respectively. CONCLUSIONS: Approximately half of smokers with indicators of poor mental health receive advice to quit during primary care consultations in the United Kingdom, and one in 10 receive a cessation medication. Interventions are lower per consultation for smokers with mental health indicators compared with smokers without mental health indicators. HubMed – addiction